6.81
1.45%
-0.10
Handel nachbörslich:
6.81
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
Atai Life Sciences executives sell shares valued at $16 million - Investing.com India
Atai Life Sciences executives sell shares valued at $16 million - Investing.com
Market Resilience: Compass Pathways Plc ADR (CMPS) Finishes Weak at 6.96, Down -0.29 - The Dwinnex
Recent Insider Activity Could Benefit Compass Pathways Plc ADR (CMPS) - Knox Daily
Examining the Potential Price Growth of Lindblad Expeditions Holdings Inc (LIND) - Knox Daily
Checking in on Terreno Realty Corp (TRNO) after recent insiders movement - Knox Daily
Compass Pathways Plc ADR (CMPS) is looking forward to a strong quarter - SETE News
Compass Pathways Plc ADR [CMPS] Records 50-Day SMA of $7.01 - Knox Daily
Compass Pathways Plc ADR Inc. (CMPS) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Ratios Uncovered: Breaking Down Compass Pathways Plc ADR (CMPS)’s Trailing Twelve Months Metrics - The Dwinnex
Can you now get a good deal on Compass Pathways Plc ADR’s shares? - US Post News
Keeping an Eye on BrightSpring Health Services Inc (BTSG) After Insider Trading Activity - Knox Daily
Compass Pathways Plc ADR [CMPS] Stock sold by Insider Malievskaia Ekaterina for $70379.0 - Knox Daily
Analyzing Southern Missouri Bancorp, Inc. (SMBC) After Recent Trading Activity - Knox Daily
SILO Pharma Inc [SILO] Investment Guide: What You Need to Know - Knox Daily
Selling Buzz: Compass Pathways Plc ADR [CMPS] 10% Owner Malievskaia Ekaterina sells 8,900 shares of the company – Knox Daily - Knox Daily
Financial Metrics Exploration: Understanding Compass Pathways Plc ADR (CMPS) Through Ratios - The Dwinnex
How does Compass Pathways Plc ADR (CMPS) change from a tortoise to a hare? - SETE News
Compass Pathways to participate in three investor conferences in September - GlobeNewswire Inc.
A year in review: Compass Pathways Plc ADR (CMPS)’s performance in the last year - US Post News
Recent Insider Activity Suggests Potential Gains for Compass Pathways Plc ADR (CMPS) - Knox Daily
Compass Pathways Plc ADR (CMPS) gets rating Initiated from RBC Capital Mkts - Knox Daily
Jackson Financial Inc (JXN) expanding its growth trajectory ahead - SETE News
Financial Snapshot: Analyzing Compass Pathways Plc ADR (CMPS)’s Key Ratio Metrics - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Informatica Inc (INFA) - SETE News
Are Compass Pathways Plc ADR (CMPS) shares a good deal now? - US Post News
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com
Compass Pathways Plc ADR (CMPS) shows promising results - US Post News
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Earnings call: COMPASS Pathways Reports Q2 2024 Progress on Psilocybin Trials - Investing.com India
Earnings call: COMPASS Pathways Reports Q2 2024 Progress on Psilocybin Trials - Investing.com
Compass Pathways Plc ADR (CMPS) Stock: Navigating a Year of Volatility - The InvestChronicle
Trading Day Triumph: Compass Pathways Plc ADR (CMPS) Ends at 6.88, a -9.83 Surge/Plunge - The Dwinnex
CNO Stock Sees Surge of Approximately 9.89% in Last Five Days - Knox Daily
1 Biotech Stock Under $10 That Could Surge 420% - Barchart
Insider Sale Alert: Compass Pathways Plc ADR [CMPS] – Is it Time to sell? - Knox Daily
MAN GRP PLC/ADR (OTCMKTS:MNGPY) Shares Cross Above 200-Day Moving Average of $1.79 - Defense World
Why the Market Dipped But XPeng Inc. Sponsored ADR (XPEV) Gained Today - Yahoo Finance
Investing in Compass Pathways Plc ADR (CMPS) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Compass Pathways initiated at 'Outperform' by RBC, cites $2.3B revenue potential - Investing.com
Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
A better buy-in window may exist right now for Compass Pathways Plc ADR (CMPS) - SETE News
The Attractiveness of Investing In Compass Pathways Plc ADR (CMPS) is Growing - Knox Daily
Compass Pathways Plc ADR [CMPS] Investment Appeal on the Rise - Knox Daily
Horizons PSYK ETF Review: The World’s First Psychedelics Fund (Sep 2024) - Wealth Awesome
Compass Pathways Plc ADR [CMPS] Shares Rise 7.30 on Wednesday – Knox Daily - Knox Daily
Compass Pathways appoints new Chief Commercial Officer By Investing.com - Investing.com India
Compass Pathways appoints new Chief Commercial Officer - Investing.com
Rivian stock retains Sell rating amid VW investment By Investing.com - Investing.com India
Compass Pathways appoints new Chief Commercial Officer By Investing.com - Investing.com UK
Compass Pathways Plc ADR (CMPS) rating initates by Morgan Stanley – Knox Daily - Knox Daily
Compass Pathways appoints Lori Englebert as Chief Commercial Officer - GlobeNewswire Inc.
B.Riley sets Buy rating on Corbus Pharma stock, cites potential By Investing.com - Investing.com India
Compass Pathways Plc ADR [CMPS] Insider Activity: An Update for Investors – Knox Daily - Knox Daily
Compass Pathways Plc ADR Inc. (CMPS) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Should You Buy the Dip on Compass Pathways Stock? - The Motley Fool
Compass Pathways Plc ADR (CMPS) Stock: A Year of Decreases and Increases - The InvestChronicle
Stock Surge: Compass Pathways Plc ADR (CMPS) Closes at 6.55, Marking a -5.62 Increase/Decrease – DWinneX - The Dwinnex
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know. - The Motley Fool
Selling Buzz: Compass Pathways Plc ADR [CMPS] 10% Owner Malievskaia Ekaterina sells 8900 shares of the ... - Knox Daily
Adversity is less terrifying than hope: Compass Pathways Plc ADR (CMPS) – Sete News - SETE News
Compass Pathways Plc ADR (CMPS) Stock: From Low to High in 52 Weeks - The InvestChronicle
Introducing Our Rant Against Compass Pathways Plc ADR – US Post News - US Post News
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment - Investing.com India
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By Investing.com - Investing.com
Citi Appointed as Successor Depositary Bank for Iberdrola, S.A.’s ADR Programme - Yahoo Finance
A stock that deserves closer examination: Compass Pathways Plc ADR (CMPS) – US Post News - US Post News
Compass Pathways insider sells over $240k in company shares - Investing.com India
Compass Pathways exec sells over $246k in company stock - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):